Bio-Pharmaceutical Industry R & D Performance Study in China
Jian Yu
Abstract
Jian Yu
Abstract
Bio pharmaceutical industry is a resource-conserving and environment-friendly industry, which is still a new industry in the world. In the process of the development of bio pharmaceutical industry in China, the advantage is the raw material procurement and marketing, the disadvantage is research and development. There are four problems in the research and development of biological medicine industry in China: The shortage of funds, the lack of compound talents, the single source of funds, and the slow development of scientific research. The two models show that the research and development of biological medicine industry in China will have a lagging effect on the development of China's pharmaceutical industry. Four suggestions are put forward: to improve the policy of biological medicine industry, to build a platform for enterprises, to improve the capital market and to train high quality talents.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Bio pharmaceutical industry is a resource-conserving and environment-friendly industry, which is still a new industry in the world. In the process of the development of bio pharmaceutical industry in China, the advantage is the raw material procurement and marketing, the disadvantage is research and development. There are four problems in the research and development of biological medicine industry in China: The shortage of funds, the lack of compound talents, the single source of funds, and the slow development of scientific research. The two models show that the research and development of biological medicine industry in China will have a lagging effect on the development of China's pharmaceutical industry. Four suggestions are put forward: to improve the policy of biological medicine industry, to build a platform for enterprises, to improve the capital market and to train high quality talents.
Key concepts: Pharmaceutical industry, Lagging, Business, China, Economic shortage, Disadvantage, Quality (philosophy), Resource (disambiguation)